Maiweibio (688062.SH): has submitted an application for H-share issuance and listing, and has published the application documents.
06/01/2025
GMT Eight
Maiwei Biotechnology (688062.SH) announced that the company submitted an application to the Hong Kong Stock Exchange on January 6, 2025 for the issuance of H shares and listing on the main board of the Hong Kong Stock Exchange. The application materials for this issuance were also published on the exchange's website on the same day.